Information about risk, prevention, screening, symptoms, diagnosis, treatment, and support for all cancers Information about cancer treatment, including surgery, chemotherapy, radiation therapy, clinical trials, proton therapy, complementary medicine, and cutting edge technologies.
Ways for cancer patients and caregivers to cope with cancer, side effects, nutrition, general cancer support issues, grief/end of life issues, and shared survivor's experiences.
Frequently Asked Questions / Types of Cancer / Breast Cancer / Breast Cancer
Last Modified: January 27, 2009
![]()
Dear OncoLink "Ask The Experts,"
My sister was diagnosed with DCIS and had mastectomy. My Mom was just diagnosed as well. My sister tested negative in the genetic testing to see if she carried the gene that would affect her daughters. Does that mean they can never get breast cancer? My sister said they are cleared, but I am not because of my Mom. Please clarify.
![]()
Jill Stopfer, MS, CGC, Certified Genetic Counselor, responds:
This is a common misconception and underscores the importance of genetic counseling by a qualified professional so people don't just have genetic testing, but understand the results, and the meaning of these results regarding their risk and follow-up recommendations.
First of all, there is a common misconception that there is one "breast cancer gene" that accounts for all inherited risk for breast cancer, or for the breast cancer that runs in families. This is not the case. There are many, many genes that may influence one’s chances of developing breast cancer. Only some of the genes have been identified so far, and only a few of them are available now for clinical (commercial) testing. The best known of these breast cancer genes are BRCA1 and BRCA2. If there is a family history of breast cancer that looks suspicious, meaning it looks to have a familial component, these two genes will be responsible only 50% of the time. This means that you can have familial, or hereditary risk for breast cancer, but have it due to something other than BRCA1/2. It's possible that a different gene, or set of genes, could underlie familial risk in the
family asking the question below. When an individual is tested and found to be negative for BRCA1/2, then the history is still unexplained, and may or may not be due to significant genetic or inherited factors.
Bottom line, risk assessment and counseling is just as important as the blood test! The daughters of this woman who tested negative may still be at increased risk. It would be inappropriate for this next generation to assume that they are at average risk just because their mother was tested and was negative for two of many possible genes that could increase breast cancer risk. In addition, there is no woman who has a zero risk for developing breast cancer, since most breast cancer cases have nothing to do with BRCA1/2. The sister is at increased risk with a mother and sister with breast cancer, and may benefit from enhanced surveillance, as will the next generation when they are older (since no ages are given I cannot say when screening should begin, but this would be discussed in a session with a genetic counselor).
Find a genetic counselor in your area through the National Society of Genetic Counselors or the National Cancer Institute.
Dr. Giantonio discusses the importance of oncology clinical trials and clarifies some myths about studies. Read more.
Cancer Types
Bone Cancer
Brain Tumors
Breast Cancer
Carcinoid Tumors
Endocrine System Cancers
Gastrointestinal Cancers
Gynecologic Cancers
Head and Neck Cancers
Leukemia
Lung Cancers
Lymphomas
Myelomas
Pediatric Cancers
Penile Cancer
Prostate Cancer
Sarcomas
Skin Cancers
Testicular Cancer
Thyroid Cancer
Urinary Tract Cancers
OncoLink Vet
Cancer Treatment
Biologic Therapy
Bone Marrow Transplants
Chemotherapy
Clinical Trials
Complementary Medicine
Gene Therapy
General Treatment Concerns
Hormone Therapy
PDT Center
Proton Therapy
Radiation Oncology
Surgical Oncology
Targeted Therapies
Vaccine Therapies
Cancer Support
Caregivers
Hospice Care and Bereavement
Nutrition and Cancer
Sexuality & Fertility
Side Effects
Support
Survivorship
Exercise and Cancer
Cancer Resources
Cancer News
OncoLink University
Nurses' Notes
Conferences
Newly Diagnosed Patients
Causes and Prevention
Legal and Financial Information for Patients
LGBT Resources
NCI Resources
Global Resources
Cancer Resource List
Resources for Young Adults
OncoLink Media Library
OncoLink TV
Book, Music and Video Reviews
Ask the Experts
Brown Bag Chat
Tracy's Corner
About OncoLink
About OncoLink
Giving to OncoLink
Contact Information
Usage Policy
Editorial Board
How to Partner with OncoLink
Link to OncoLink
Mission Statement
Calcium Leucovorin, Citrovorum Factor, Folinic Acid
Cladribine (2-CDA, Leustatin®)
Cyclophosphamide (Cytoxan®, Neosar®, Endoxan®)
Cyclosporine (Neoral®, Sandimmune®, Restasis®, Gengraf®)
Cytarabine (Cytosar-U®, Ara-C)
Irinotecan (Camptosar®, CPT-11)
Leucovorin (Calcium Leucovorin, Citrovorum Factor, Folinic Acid)
Calcium Leucovorin, Citrovorum Factor, Folinic Acid
Leucovorin (Calcium Leucovorin, Citrovorum Factor, Folinic Acid)
Leuprolide Acetate (Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®) - For Men
Leuprolide Acetate (Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®) - For Women
Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®
Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®
Busulfan (Myleran®, Busulfex®)
Intravesicular Mitomycin (Mutamycin®, Mitomycin-C, given into the bladder)
Mechlorethamine (Mustargen®, Nitrogen Mustard)
mechlorethamine, mustine, Mustargen®
Megestrol (Megace®, Megace-ES®)
Mercaptopurine (Purinethol®, 6-MP)
Methotrexate (Mexate®, Folex®, Rheumatrex®, Amethopterin, MTX)
Mexate®, Folex®, Rheumatrex®, Amethopterin, MTX
Mitomycin (Mutamycin®, Mitomycin-C)
Morphine Sulfate (Given by IV)
Morphine Sulfate (MS Contin®, Avinza®, Kadian®, Oramorph SR®)
MS Contin®, Avinza®, Kadian®, Oramorph SR®
Mutamycin®, Mitomycin-C, given into the bladder
Nitrogen mustard (mechlorethamine, mustine, Mustargen®)
Bendamustine Hydrochloride (Treanda®)
Bexarotene (Targretin®), Oral Formulation
Bexarotene Gel (Targretin® Gel Formulation)
Etoposide (Toposar®, VePesid®, Etopophos®,VP-16)
Thioguanine (6-TG, Thioguanine Tabloid®)
Toposar®, VePesid®, Etopophos®,VP-16
Trelstar LA® and Trelstar Depot®
Tretinoin (Vesanoid®, All-Trans-Retinoic Acid, ATRA)
Triptorelin (Trelstar LA® and Trelstar Depot®)

